Pregled bibliografske jedinice broj: 67708
Ikaros expression in human lymphoproliferative disorders
Ikaros expression in human lymphoproliferative disorders // Signal transduction / Đikić, Ivan ; Pavelić, Jasminka ; Husnjak, Koraljka (ur.).
Zagreb: Institut Ruđer Bošković, 2000. str. 103-103 (poster, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 67708 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Ikaros expression in human lymphoproliferative disorders
Autori
Kušić, Borka ; Bačić, Sanja ; Herak Bosnar, Maja ; Dominis, Marija ; Antica, Mariastefania
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Signal transduction
/ Đikić, Ivan ; Pavelić, Jasminka ; Husnjak, Koraljka - Zagreb : Institut Ruđer Bošković, 2000, 103-103
Skup
Second international conference on signal transduction
Mjesto i datum
Cavtat, Hrvatska, 26.05.2000. - 31.05.2000
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
Ikaros; transcription factors; lymphoproliferative disorders
Sažetak
Commitment of hematopoietic progenitors into the lymphoid lineage, as well as the choice of effector function at later stages of this differentiation pathway, are dependent upon the tightly controlled transcription activation and/or repression of gene expression. Genetic studies have shown Ikaros to be essential regulator of lymphocyte differentiation and homeostasis.This transcription factor is alternative splicing variant of primary RNA transcripts and it belongs to the family of zinc finger proteins that specifically bind to DNA. It has been shown in mice that dimerization deficient isoforms of Ikaros fail to transactivate target genes, and lead to lymphoproliferation and lymphoma development. On the other hand Ikaros and related proteins can repress transcription from specific promotors in a cell type-dependent manner. The aim of the present study is to analyse human lymphoid malignancies in order to check whether Ikaros expression in these disorders is impaired. We analysed Ikaros gene expression in human lymphocytes by amplifiing mRNA transcripts for the Ikaros isoforms Ik1, Ik2, Ik3 and Ik4. By means of RT-PCR method and specific primers we analysed Ikaros expression in human lymphoid cell lines (Jurkat, MOLT, NALM), in lymph nodes from Non-Hodgkin's lymphoma patients and in peripheral blood lymphocytes from chronic lymphocytic B cell leukaemia patients. In spite of the multiple defects observed in the lymphoid compartment of the Ikaros mutant mice, we found Ikaros gene expression at the level of mRNA in all tested human leukaemic cell lines and lymphomas. Still, we cannot exclude the possibility that Ikaros function might be impaired by point mutation(s), or by different levels of isoforme expression. Sequencing of the transcripts will give us more insight into ther nature and their relevance in lymphoproliferative disease development.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb
Profili:
Maja Herak Bosnar
(autor)
Marija Dominis
(autor)
Mariastefania Antica
(autor)
Borka Kušić
(autor)